mirvetuximab
Immunogen
['ovarian']
excellent news for our patients with ovarian cancer and amazing to see os benefit in this disease. #asco2023 
Gynecologic Oncologist at Rutgers Cancer Institute of New Jersey.        Clinical trials/ developmental therapeutics.